Albert Català Temprano
Investigador
Research group
Professional network profiles
Last Publications
- Río P, Zubicaray J, Navarro S, Gálvez E, Sánchez-Domínguez R, Nicoletti E, Sebastián E, Rothe M, Pujol R, Bogliolo M, John-Neek P, Bastone AL, Schambach A, Wang W, Schmidt M, Larcher L, Segovia JC, Yáñez RM, Alberquilla O, Díez B, Fernández-García M, García-García L, Ramírez M, Galy A, Lefrere F, Cavazzana M, Leblanc T, García de Andoin N, López-Almaraz R, Català-Temprano A, Barquinero J, Rodríguez-Perales S, Rao G, Surrallés J, Soulier J, Díaz-de-Heredia C, Schwartz JD, Sevilla J and Bueren JA Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials. Lancet . 404(10471): 2584-2592.
- Romero-Moya D, Torralba-Sales E, Calvo C, Marin-Bejar O, Magallon-Mosella M, Distefano-Muñoz ME, Pera J, Juan Castaños Asins, De Giorgio F, Gonzalez J, Iglesias A, Berenguer-Balaguer C, Schilling M, Plass M, Pasquali L, Català-Temprano A, Molina O, Wlodarski MW, Bigas A and Giorgetti A CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitness Leukemia . 39(12): 3015-3025.
- Pera J, Romero-Moya D, Torralba-Sales E, Andersson R, García-Hernández V, Magallon-Mosella M, Distefano M, Berenguer Balaguer C, Juan Castaños Asins, De Giorgio F, Qiu Z, Iglesias A, Spurk P, Montserrat-Vazquez S, Pasquali L, Liang Z, Català-Temprano A, Florian MC, Wlodarski MW, Bigas A, Marin-Bejar O and Giorgetti A Human iPSCs-based modeling unveils SETBP1 as a driver of chromatin rewiring in GATA2 deficiency NATURE COMMUNICATIONS . 16(1): 10035-10035.
Projects
- Project name:
- ADVANCED THERAPIES (RICORS-TERAV)
- Leader
- Susana Rives Solà
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- RD24/0014/0006
- Starting - finishing date:
- 2025 - 2027
- Project name:
- Estudio multicéntrico fase 2 en pacientes pediátricos (0-18 años) con leucemia linfoblástica aguda B CD19+ en recaída o refractaria
- Leader
- Susana Rives Solà
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- ICI21/00033
- Starting - finishing date:
- 2022 - 2026
- Project name:
- New approaches for the identification and functional characterization of prognostic genetic biomarkers in inherited childhood myelodysplastic/acute leukemia syndromes Acronym: GEMMA
- Leader
- Albert Català Temprano
- Funding entities:
- Fundació La Marató de TV3
- Code
- 202001-30
- Starting - finishing date:
- 2021 - 2024
News
-
Genetic events that could trigger leukemia in patients with a rare genetic disorder are deciphered
The study has been carried out thanks to advanced models of this genetic disorder generated by the researchers, which are presented as a key tool in its investigation.
